Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8166
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor ; volume:8 ; number:1 ; day:31 ; month:1 ; year:2015 ; pages:1-7 ; date:12.2015
Molecular cytogenetics ; 8, Heft 1 (31.1.2015), 1-7, 12.2015
- Creator
-
Bobadilla-Morales, Lucina
Pimentel-Gutiérrez, Helia J.
Gallegos-Castorena, Sergio
Paniagua-Padilla, Jenny A.
Ortega-de-la-Torre, Citlalli
Sánchez-Zubieta, Fernando
Silva-Cruz, Rocio
Corona-Rivera, Jorge R.
Zepeda-Moreno, Abraham
González-Ramella, Oscar
Corona-Rivera, Alfredo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13039-014-0105-4
- URN
-
urn:nbn:de:101:1-2021082422022271736449
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bobadilla-Morales, Lucina
- Pimentel-Gutiérrez, Helia J.
- Gallegos-Castorena, Sergio
- Paniagua-Padilla, Jenny A.
- Ortega-de-la-Torre, Citlalli
- Sánchez-Zubieta, Fernando
- Silva-Cruz, Rocio
- Corona-Rivera, Jorge R.
- Zepeda-Moreno, Abraham
- González-Ramella, Oscar
- Corona-Rivera, Alfredo
- SpringerLink (Online service)
Other Objects (12)
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
Donor engrafted clonal hematopoiesis of indeterminate potential in allogeneic hematopoietic stem cell transplantation
Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia
DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell transplantation
Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation
Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation
Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation
Induction of leukemia reactive, allogeneic donor lymphocytes
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
Donor engrafted clonal hematopoiesis of indeterminate potential in allogeneic hematopoietic stem cell transplantation
Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia
DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell transplantation
Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation
Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation
Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation
Induction of leukemia reactive, allogeneic donor lymphocytes
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
Donor engrafted clonal hematopoiesis of indeterminate potential in allogeneic hematopoietic stem cell transplantation
Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia
DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell transplantation
Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation
Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation
Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation